Wellgistics Health Board Approves $8.1M Debt-To-Equity Conversion

-6.90% Pre

Wellgistics Health

WGRX

0.54

0.56

-6.90%

+3.69% Pre

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that its Board of Directors has approved an $8.1 million debt-to-equity conversion.

Led by CEO Brian Norton and former minority partners of Wellgistics, LLC, which was acquired by Wellgistics Health in 2024, the transaction strengthens the Company's balance sheet by materially reducing the Company's short-term debt.

The transaction is also expected to:

Accelerate the Company's cash flow by unlocking more favorable terms and capital access;

Improve Wellgistics Health's ability to acquire high-demand pharmaceutical products at competitive prices;

Expand the Company's national footprint by growing its network of independent pharmacies; and

Strengthen the Company's proprietary technology platform, including AI-powered hub services and digital prescription routing

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.